CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021		70,896,856
Beginning balance at Dec. 31, 2021	$ 1,050,233	$ 1	$ 1,095,229	$ (155,947)	$ 112,267	$ (1,317)
Beginning balance (in shares) at Dec. 31, 2021				20,220,227
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock	(74)		(74)
Issuance of common stock under employee plans, net (in shares)		566,780
Issuance of common stock under employee plans, net	(4,870)		(4,870)
Stock-based compensation	106,176		106,176
Issuance of common stock for business combination contingent consideration and related tax effects (in shares)		10,945
Tax benefit related to convertible note hedge	48,858		48,858
Purchase of convertible note hedge	(194,994)		(194,994)		0
Issuance of warrants	124,269		124,269			0
Net income	146,930				146,930
Other comprehensive (loss) income, net	(5,862)					(5,862)
Ending balance (in shares) at Dec. 31, 2022		71,474,581
Ending balance at Dec. 31, 2022	1,270,666	$ 1	1,174,594	$ (155,947)	259,197	(7,179)
Ending balance (in shares) at Dec. 31, 2022				20,220,227
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		467,594
Issuance of common stock	94,705		94,705
Issuance of common stock under employee plans, net (in shares)		1,441,279
Issuance of common stock under employee plans, net	(107,894)		(107,894)
Stock-based compensation	131,358		131,358
Issuance of common stock for business combination contingent consideration and related tax effects (in shares)		10,944
Stock options exercised (in shares)		1,907,026
Stock options exercised	54,503		54,503
Issuance of common stock for business combination contingent consideration and related tax effects	144		144
Net income	175,783				175,783
Other comprehensive (loss) income, net	$ (3,500)					(3,500)
Ending balance (in shares) at Dec. 31, 2023	75,301,424	75,301,424
Ending balance at Dec. 31, 2023	$ 1,615,765	$ 1	1,347,410	$ (155,947)	434,980	(10,679)
Ending balance (in shares) at Dec. 31, 2023	20,220,227			20,220,227
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee plans, net (in shares)		804,780
Issuance of common stock under employee plans, net	$ (58,178)		(58,178)
Stock-based compensation	382,604		382,604
Issuance of common stock for business combination contingent consideration and related tax effects (in shares)		3,127
Stock options exercised (in shares)		510,000
Stock options exercised	14,576		14,576
Issuance of common stock for business combination contingent consideration and related tax effects	498		498
Issuance of replacement awards in connection with business combinations	2,871		2,871
Net income	377,034				377,034
Other comprehensive (loss) income, net	$ (7,505)					(7,505)
Ending balance (in shares) at Dec. 31, 2024	76,619,331	76,619,331
Ending balance at Dec. 31, 2024	$ 2,327,665	$ 1	$ 1,689,781	$ (155,947)	$ 812,014	$ (18,184)
Ending balance (in shares) at Dec. 31, 2024	20,220,227			20,220,227